Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 4085045
[patent_doc_number] => 06132976
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-17
[patent_title] => 'Immunoassays for the measurement of collagen denaturation and cleavage in cartilage'
[patent_app_type] => 1
[patent_app_number] => 9/010999
[patent_app_country] => US
[patent_app_date] => 1998-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 30
[patent_no_of_words] => 25028
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/132/06132976.pdf
[firstpage_image] =>[orig_patent_app_number] => 010999
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/010999 | Immunoassays for the measurement of collagen denaturation and cleavage in cartilage | Jan 21, 1998 | Issued |
Array
(
[id] => 3991728
[patent_doc_number] => 05919634
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-06
[patent_title] => 'Methods of detecting collagen type II degradation in vivo'
[patent_app_type] => 1
[patent_app_number] => 9/000605
[patent_app_country] => US
[patent_app_date] => 1997-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 13
[patent_no_of_words] => 10409
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/919/05919634.pdf
[firstpage_image] =>[orig_patent_app_number] => 000605
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/000605 | Methods of detecting collagen type II degradation in vivo | Dec 29, 1997 | Issued |
Array
(
[id] => 4083062
[patent_doc_number] => 06162631
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-19
[patent_title] => 'Retrovirus from the HIV group and its use (MVP-2901/94)'
[patent_app_type] => 1
[patent_app_number] => 8/989493
[patent_app_country] => US
[patent_app_date] => 1997-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7838
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/162/06162631.pdf
[firstpage_image] =>[orig_patent_app_number] => 989493
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/989493 | Retrovirus from the HIV group and its use (MVP-2901/94) | Dec 11, 1997 | Issued |
Array
(
[id] => 3941728
[patent_doc_number] => 05976813
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-02
[patent_title] => 'Continuous format high throughput screening'
[patent_app_type] => 1
[patent_app_number] => 8/990168
[patent_app_country] => US
[patent_app_date] => 1997-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 15
[patent_no_of_words] => 11005
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/976/05976813.pdf
[firstpage_image] =>[orig_patent_app_number] => 990168
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/990168 | Continuous format high throughput screening | Dec 11, 1997 | Issued |
08/976741 | MIMICS OF CD4 WITH ENHANCED AFFINITY FOR HUMAN IMMUNODEFICIENCY VIRUS ENVELOPE GLYCOPROTEIN GP120 | Nov 23, 1997 | Abandoned |
Array
(
[id] => 1527846
[patent_doc_number] => 06479246
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-12
[patent_title] => 'Competitive binding assay immunoassay for platelet antigens in whole blood'
[patent_app_type] => B1
[patent_app_number] => 08/913457
[patent_app_country] => US
[patent_app_date] => 1997-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 4125
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/479/06479246.pdf
[firstpage_image] =>[orig_patent_app_number] => 08913457
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/913457 | Competitive binding assay immunoassay for platelet antigens in whole blood | Nov 19, 1997 | Issued |
Array
(
[id] => 3928566
[patent_doc_number] => 05972339
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-26
[patent_title] => 'Method of eliciting anti-HIV-1 helper T cell responses'
[patent_app_type] => 1
[patent_app_number] => 8/969721
[patent_app_country] => US
[patent_app_date] => 1997-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 5
[patent_no_of_words] => 8358
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/972/05972339.pdf
[firstpage_image] =>[orig_patent_app_number] => 969721
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/969721 | Method of eliciting anti-HIV-1 helper T cell responses | Nov 12, 1997 | Issued |
Array
(
[id] => 4194665
[patent_doc_number] => 06043348
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-28
[patent_title] => 'Antibody recognizing a small subset of human hematopoietic cells'
[patent_app_type] => 1
[patent_app_number] => 8/970032
[patent_app_country] => US
[patent_app_date] => 1997-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15378
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/043/06043348.pdf
[firstpage_image] =>[orig_patent_app_number] => 970032
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/970032 | Antibody recognizing a small subset of human hematopoietic cells | Nov 12, 1997 | Issued |
Array
(
[id] => 3981410
[patent_doc_number] => 05861243
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-19
[patent_title] => 'Vaccine for protection against HIV infections, process for preparing same and their use as diagnostic and agent immunotherapeutic agent'
[patent_app_type] => 1
[patent_app_number] => 8/968689
[patent_app_country] => US
[patent_app_date] => 1997-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 4899
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/861/05861243.pdf
[firstpage_image] =>[orig_patent_app_number] => 968689
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/968689 | Vaccine for protection against HIV infections, process for preparing same and their use as diagnostic and agent immunotherapeutic agent | Nov 11, 1997 | Issued |
08/966932 | COMPOUNDS INHIBITING CD4-GP120 INTERACTION AND USES THEREOF | Nov 9, 1997 | Abandoned |
Array
(
[id] => 1577826
[patent_doc_number] => 06448077
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-10
[patent_title] => 'Chimeric and humanized monoclonal antibodies specific to VEGF receptors'
[patent_app_type] => B1
[patent_app_number] => 08/967113
[patent_app_country] => US
[patent_app_date] => 1997-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 12799
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/448/06448077.pdf
[firstpage_image] =>[orig_patent_app_number] => 08967113
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/967113 | Chimeric and humanized monoclonal antibodies specific to VEGF receptors | Nov 9, 1997 | Issued |
Array
(
[id] => 4151276
[patent_doc_number] => 06156315
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-05
[patent_title] => 'Method for inhibiting the binding of low density lipoprotein to blood vessel matrix'
[patent_app_type] => 1
[patent_app_number] => 8/966296
[patent_app_country] => US
[patent_app_date] => 1997-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 6022
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/156/06156315.pdf
[firstpage_image] =>[orig_patent_app_number] => 966296
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/966296 | Method for inhibiting the binding of low density lipoprotein to blood vessel matrix | Nov 6, 1997 | Issued |
Array
(
[id] => 4043628
[patent_doc_number] => 05912131
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-06-15
[patent_title] => 'Detection of type 1 collagen degradation in vivo'
[patent_app_type] => 1
[patent_app_number] => 8/965699
[patent_app_country] => US
[patent_app_date] => 1997-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7209
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/912/05912131.pdf
[firstpage_image] =>[orig_patent_app_number] => 965699
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/965699 | Detection of type 1 collagen degradation in vivo | Nov 6, 1997 | Issued |
Array
(
[id] => 4212940
[patent_doc_number] => 06110689
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-29
[patent_title] => 'Method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen'
[patent_app_type] => 1
[patent_app_number] => 8/963825
[patent_app_country] => US
[patent_app_date] => 1997-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 18298
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/110/06110689.pdf
[firstpage_image] =>[orig_patent_app_number] => 963825
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/963825 | Method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen | Nov 3, 1997 | Issued |
Array
(
[id] => 3948306
[patent_doc_number] => 05872713
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-16
[patent_title] => 'Synchronized analyte testing system'
[patent_app_type] => 1
[patent_app_number] => 8/960866
[patent_app_country] => US
[patent_app_date] => 1997-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 5937
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 195
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/872/05872713.pdf
[firstpage_image] =>[orig_patent_app_number] => 960866
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/960866 | Synchronized analyte testing system | Oct 29, 1997 | Issued |
Array
(
[id] => 3922809
[patent_doc_number] => 05945293
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-31
[patent_title] => 'Protein-colloidal metal-aminodextran coated particle and methods of preparation and use'
[patent_app_type] => 1
[patent_app_number] => 8/947811
[patent_app_country] => US
[patent_app_date] => 1997-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 15
[patent_no_of_words] => 18043
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/945/05945293.pdf
[firstpage_image] =>[orig_patent_app_number] => 947811
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/947811 | Protein-colloidal metal-aminodextran coated particle and methods of preparation and use | Oct 8, 1997 | Issued |
Array
(
[id] => 4280237
[patent_doc_number] => 06210654
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-03
[patent_title] => 'Jak kinases and regulation of cytokine signal transduction'
[patent_app_type] => 1
[patent_app_number] => 8/946994
[patent_app_country] => US
[patent_app_date] => 1997-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 42549
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/210/06210654.pdf
[firstpage_image] =>[orig_patent_app_number] => 946994
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/946994 | Jak kinases and regulation of cytokine signal transduction | Oct 7, 1997 | Issued |
Array
(
[id] => 3966893
[patent_doc_number] => 05978466
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-02
[patent_title] => 'Method and system for anonymously testing for a human malady'
[patent_app_type] => 1
[patent_app_number] => 8/942903
[patent_app_country] => US
[patent_app_date] => 1997-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 8332
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/978/05978466.pdf
[firstpage_image] =>[orig_patent_app_number] => 942903
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/942903 | Method and system for anonymously testing for a human malady | Oct 1, 1997 | Issued |
Array
(
[id] => 4079450
[patent_doc_number] => 06054265
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-04-25
[patent_title] => 'Screening assays for compounds that inhibit membrane fusion-associated events'
[patent_app_type] => 1
[patent_app_number] => 8/919597
[patent_app_country] => US
[patent_app_date] => 1997-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 83
[patent_figures_cnt] => 83
[patent_no_of_words] => 284815
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/054/06054265.pdf
[firstpage_image] =>[orig_patent_app_number] => 919597
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/919597 | Screening assays for compounds that inhibit membrane fusion-associated events | Sep 25, 1997 | Issued |
Array
(
[id] => 4046774
[patent_doc_number] => 05932223
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-03
[patent_title] => 'Rotavirus vaccine formulations'
[patent_app_type] => 1
[patent_app_number] => 8/938260
[patent_app_country] => US
[patent_app_date] => 1997-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 23
[patent_no_of_words] => 7466
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/932/05932223.pdf
[firstpage_image] =>[orig_patent_app_number] => 938260
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/938260 | Rotavirus vaccine formulations | Sep 25, 1997 | Issued |